Strongyloides ferreirai Rodrigues, Vicente & Gomes, 1985 (Nematoda, Rhabdiasoidea) in rodent coprolites (8.000-2.000 years BP), from archaeological sites from Piauí, Brazil

Eggs and larvae of Strongyloides ferreirai Rodrigues, Vicente & Gomes, 1985 are identified in Kerodon rupestris (Wied.) coprolites dated from 8.000-2.000 years BP (Before Present), collected from archaeological sites from the northeast of Brazil.

Biological control of Biomphalaria tenagophila (Mollusca, Planorbidae), a schistosomiasis vector, using the fish Geophagus brasiliensis (Pisces, Cichlidae) in the laboratory or in a seminatural environment

In order to investigate a possible method of biological control of schistosomiasis, we used the fish Geophagus brasiliensis (Quoy & Gaimard, 1824) which is widely distributed throughout Brazil, to interrupt the life cycle of the snail Biomphalaria tenagophila (Orbigny, 1835), an intermediate host of Schistosoma mansoni. In the laboratory, predation eliminated 97.6% of the smaller snails (3-8 mm shell diameter) and 9.2% of the larger ones (12-14 mm shell diameter). Very promising results were also obtained in a seminatural environment. Studies of this fish in natural snail habitats should be further encouraged.

On the immature stages of two mosquitoes (Diptera: Culicidae) originally described from Rio de Janeiro, Brazil

The fourth-instar larva and pupa of Psorophora pseudomelanota Barata & Cotrim, 1971 and Phoniomyia deanei Lourenço-de-Oliveira, 1983 are described and compared with those of related species.

Wyeomyia staminifera, a new species of mosquito from Brazil (Diptera: Culicidae)

Wyeomia staminifera n. sp. is described from specimens collected into the forest of the Amazon and Southeast Regions of Brazil. The description includes illustrations of female and male genitalias and chaetotaxy of pupa and larva. Wy. staminifera is closely related to Wy. aporonoma, but they are distinguishable in all stages.

The Trypanosoma cruzi Genome Project: Nuclear Karyotype and Gene Mapping of Clone CL Brener

By using improved pulsed field gel electrophoresis conditions, the molecular karyotype of the reference clone CL Brener selected for Trypanosoma cruzi genome project was established. A total of 20 uniform chromosomal bands ranging in size from 0.45 to 3.5 Megabase pairs (Mbp) were resolved in a single run. The weighted sum of the chromosomal bands was approximately 87 Mbp. Chromoblots were hybridized with 39 different homologous probes, 13 of which identified single chromosomes. Several markers showed linkage and four different linkage groups were identified, each comprising two markers. Densitometric analysis suggests that most of the chromosomal bands contain two or more chromosomes representing either homologous chromosomes and/or heterologous chromosomes with similar sizes

Narrativa de mujeres en Costa Rica: personajes femeninos en los Cuentos de mi tía Panchita

Este trabajo tiene como objetivo el adentrarse en algunos de los cuentos infantiles de una reconocida autora de Costa Rica, los Cuentos de mi tía Panchita de Carmen Lyra, y descubrir, mediante un análisis de ciertos de sus personajes femeninos desde un marco relacionado con teoría literaria feminista, elementos del discurso que permitan entrever o evidenciar la presencia de roles tradicionales de las mujeres o transgresiones a esos patrones, con mayor atención a la Costa Rica de principios del siglo XX

Trypanosoma cruzi-cardiomyocytes: new contributions regarding a better understanding of this interaction

The present paper summarizes new approaches regarding the progress done to the understanding of the interaction of Trypanosoma cruzi-cardiomyocytes. Mannose receptors localized at the surface of heart muscle cell are involved in binding and uptake of the parasite. One of the most striking events in the parasite-heart muscle cells interaction is the disruption of the actin cytoskeleton. We have investigated the regulation of the actin mRNA during the cytopathology induced in myocardial cells by the parasite. T. cruzi invasion increases calcium resting levels in cardiomyocytes. We have previously shown that Ca2+ ATPase of the sarcoplasmic reticulum (SERCA) is involved in the invasion of T. cruzi in cardiomyocytes. Treating the cells with thapsigargin, a drug that binds to all SERCA ATPases and causes depletion of intracellular calcium stores, we found a 75% inhibition in the T. cruzi-cardiomyocytes invasion.

Impacto de la utilización de hígados de donantes anti-HBc positivo en pacientes trasplantados por hepatitis B

El nostre objectiu és avaluar l’impacte de la utilització de fetges de donants anti-HBc positius en pacients trasplantats per hepatitis B, els quals van ser revisats de manera retrospectiva. La probabilitat acumulada d’hepatitis B post-trasplantament al 1er, 5é i 10é any va ésser del 3,7%, 8,3% i 8,3% en els receptors d’un empelt anti-HBc+ en comparació amb el 2,7%, 9,8% i 9,8% en els que varen rebre un empelt anti-HBc- (p=0,99). La probabilitat de supervivència al 1er, 5é i 10é any dels receptors d’un òrgan anti-HBc+ va ésser del 87%, 82% i 58% front al 87%, 82% i 74% en els que varen rebre un anti-HBc- (p=0,73). La utilització de donants anti-HBc positius no afecta ni a la supervivència ni al desenvolupament de hepatitis B en pacients trasplantats per VHB.

Effect of interferon-alpha on experimental septal fibrosis of the liver - study with a new model

Interferon-alpha is used in antiviral therapy in humans, mainly for viral hepatitis B and C. An anti-fibrotic effect of interferon has been postulated even in the absence of anti-viral response, which suggests that interferon directly inhibits fibrogenesis. Rats infected with the helminth Capillaria hepatica regularly develop diffuse septal fibrosis of the liver, which terminates in cirrhosis 40 days after inoculation. The aim of this study was to test the anti-fibrotic effect of interferon in this experimental model. Evaluation of fibrosis was made by three separate methods: semi-quantitative histology, computerized morphometry and hydroxyproline measurements. Treatment with interferon-alpha proved to inhibit the development of fibrosis in this model, especially when doses of 500,000 and 800,000 IU were used for 60 days. Besides confirming the anti-fibrotic potential of interferon-alpha on a non-viral new experimental model of hepatic fibrosis, a clear-cut dose-dependent effect was observed.